Federal Circuit Tosses Diagnostic Patent, Spurring Biopharma Calls For Congressional Action

 
• By Brenda Sandburg
Research analyst adding reagent to drug to keep tracking chemical reaction - Image

More from Legal & IP

More from Pink Sheet